MDM2 promoter polymorphism and pancreatic cancer risk and prognosis.
Asomaning K, Reid AE, Zhou W, Heist RS, Zhai R, Su L, Kwak EL, Blaszkowsky L, Zhu AX, Ryan DP, Christiani DC, Liu G.
Asomaning K, et al.
Clin Cancer Res. 2008 Jun 15;14(12):4010-5. doi: 10.1158/1078-0432.CCR-07-4187.
Clin Cancer Res. 2008.
PMID: 18559624